BioLineRx Ltd. (TLV:BLRX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2.200
+0.100 (4.76%)
May 29, 2025, 5:24 PM IDT

BioLineRx Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-9.22-60.61-24.95-27.05-30.02
Depreciation & Amortization
3.991.330.650.70.93
Other Amortization
0.740.060.17-0.59
Asset Writedown & Restructuring Costs
1.266.7---
Stock-Based Compensation
1.142.322.251.51.27
Other Operating Activities
-19.9612.4-5.61.825.3
Change in Accounts Receivable
-2.12-0.36---
Change in Inventory
-1.19-1.95---
Change in Accounts Payable
-5.515.511.89-0.56-1.72
Change in Unearned Revenue
-12.9612.96---
Change in Other Net Operating Assets
-0.04-0.96-0.650.020.43
Operating Cash Flow
-43.87-22.61-26.24-23.57-23.21
Capital Expenditures
-0.05-0.12-0.13-0.1-
Sale (Purchase) of Intangibles
-0-0.18-0.19--
Investment in Securities
29.431.744.32-38.1316.67
Investing Cash Flow
29.371.444.01-38.2216.67
Long-Term Debt Issued
19.22-9.13--
Long-Term Debt Repaid
-14.94-1.99-3.05-3.57-3.36
Net Debt Issued (Repaid)
4.28-1.996.07-3.57-3.36
Issuance of Common Stock
16.3817.0414.3661.3221.22
Financing Cash Flow
20.6615.0620.4457.7517.87
Foreign Exchange Rate Adjustments
0.02-0.22-0.610.210.21
Net Cash Flow
6.18-6.33-2.4-3.8411.53
Free Cash Flow
-43.93-22.72-26.37-23.67-23.21
Free Cash Flow Margin
-151.78%-473.42%---
Free Cash Flow Per Share
-0.04-0.02-0.03-0.04-0.09
Cash Interest Paid
10.391.110.590.680.99
Levered Free Cash Flow
-43.892.33-15.32-14.54-13.66
Unlevered Free Cash Flow
-38.213.67-14.2-13.92-12.74
Change in Net Working Capital
32.06-27.13-1.270.541.29
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.